Coeptis Therapeutics Holdings, Inc. (COEP)
Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops and commercializes generic and branded pharmaceutical products and cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors. and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. was founded in 2017 and is headquartered in Wexford, Pennsylvania.
$7.63M
4.00
Wexford, PA
Jan 08, 2021
-0.41
$-0.47
0.43
0.55
-1,068.89%
-0.42
-0.00
0.95
4.79
0.55
-136.64%
-308.83%
Similar stocks (15)
Genelux Corporation
GNLX
Dyadic International, Inc.
DYAI
SeaStar Medical Holding Corporation
ICU
Monopar Therapeutics Inc.
MNPR
Cingulate Inc.
CING
Plus Therapeutics, Inc.
PSTV
Virios Therapeutics, Inc.
VIRI
Sonnet BioTherapeutics Holdings, Inc.
SONN
Palisade Bio, Inc.
PALI
Revelation Biosciences, Inc.
REVB
Allarity Therapeutics, Inc.
ALLR
Kiromic BioPharma, Inc.
KRBP
Aditxt, Inc.
ADTX
Quoin Pharmaceuticals, Ltd.
QNRX
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (15)
Genelux Corporation
GNLX
Dyadic International, Inc.
DYAI
SeaStar Medical Holding Corporation
ICU
Monopar Therapeutics Inc.
MNPR
Cingulate Inc.
CING
Plus Therapeutics, Inc.
PSTV
Virios Therapeutics, Inc.
VIRI
Sonnet BioTherapeutics Holdings, Inc.
SONN
Palisade Bio, Inc.
PALI
Revelation Biosciences, Inc.
REVB
Allarity Therapeutics, Inc.
ALLR
Kiromic BioPharma, Inc.
KRBP
Aditxt, Inc.
ADTX
Quoin Pharmaceuticals, Ltd.
QNRX
Comera Life Sciences Holdings, Inc.
CMRA
ETF Exposure (2)
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Extended Market Index Fund
VXF
0%